Carregant...
Discovery and validation of new molecular targets in treating dyslipidemia: The role of human genetics
Several high profile failures of lipid-related therapeutics in clinical trials have led to intense interest in improved discovery and preclinical prioritization of potential targets. The careful study of patients with rare monogenic disorders has played a key role in establishing the causal role of...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328807/ https://ncbi.nlm.nih.gov/pubmed/20211435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2009.12.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|